Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-07489-x.pdf
Reference30 articles.
1. Perou, C. M. Molecular stratification of triple-negative breast cancers. Oncologist. 16, 61–70 (2011).
2. Goldhirsch, A. et al. Panel embers. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 24, 2206–23 (2013).
3. Baselga, J. et al. Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer. J Clin Oncol. 31, 2586–92 (2013).
4. Lehmann, B. D. & Pietenpol, J. A. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes. J Pathol. 232, 142–50 (2014).
5. Joensuu H. et al. Adjuvent Capecitabine in combinaison with Docetaxel, Epirubicin, and cyclophosphamide for early breast cancer: the randomized clinical finXX trial. JAMA Oncol. (2017).
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer;European Journal of Pharmacology;2024-10
2. Chrysin Enhances Anti‐Cancer Activity of Jurkat T Cell and NK‐92 Cells Against Human Breast Cancer Cell Lines;Chemistry & Biodiversity;2024-09-04
3. Combined Effect of Sertraline and Capecitabine on Breast Cancer Cell Lines In Vitro and In Silico Evidence for Synergistic Interaction;Scientia Pharmaceutica;2024-07-15
4. Autophagy‐Inducing MoO3‐x Nanowires Boost Photothermal‐Triggered Cancer Immunotherapy;Angewandte Chemie International Edition;2024-06-11
5. Autophagy‐Inducing MoO3‐x Nanowires Boost Photothermal‐Triggered Cancer Immunotherapy;Angewandte Chemie;2024-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3